Fetal and Neonatal Alloimmune Thrombocytopenia
📧 Sign up to get email alerts when something new happens for Fetal and Neonatal Alloimmune Thrombocytopenia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: A Study of Nipocalimab in Reducing the Risk of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT) [Phase 3]
This document provides an update on a Phase 3 study evaluating Nipocalimab to reduce fetal and neonatal alloimmune thrombocytopenia (FNAIT).…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: A Study of Nipocalimab or Intravenous Immunoglobulin (IVIG) in Pregnancies At Risk of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT) [Phase 3]
A Phase 3 clinical trial comparing Nipocalimab to intravenous immunoglobulin (IVIG) in pregnancies at risk for fetal and neonatal alloimmune…